Redox regulation of botulinum neurotoxin toxicity: Therapeutic implications

Trends in Molecular Medicine

Volumn 20, Issue 11, 2014, Pages 602-603

  Montal, Mauricio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Botulism; Channel; Chaperone; Protease; SNAREs; Thioredoxin

Indexed keywords

BOTULINUM TOXIN; DISULFIDE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; THIOREDOXIN; THIOREDOXIN REDUCTASE; ZINC ION;

BINDING SITE; CHEMOPROPHYLAXIS; CLOSTRIDIUM BOTULINUM; CONFORMATIONAL TRANSITION; HEAVY CHAIN; HOMEOSTASIS; HUMAN; NEUROTOXICITY; NEUROTROPISM; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN SECRETION; SHORT SURVEY; SYNAPSE VESICLE; BOTULISM; METABOLISM;

BOTULINUM TOXINS; BOTULISM; HUMANS; OXIDATION-REDUCTION; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS;

EID: 84909647765     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.09.005     Document Type: Short Survey

References (10)

1. Rossetto O., et al. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat. Rev. Microbiol. 2014, 12:535-549.
2. Montal M. Botulinum neurotoxin: a marvel of protein design. Annu. Rev. Biochem. 2010, 79:591-617.
3. Colasante C., et al. Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction. Mol. Neurobiol. 2013, 48:120-127.
4. Fischer A., Montal M. Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes. J. Biol. Chem. 2007, 282:29604-29611.
5. Pirazzini M., et al. Thioredoxin and its reductase are present on synaptic vesicles and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep. 2014, 10.1016/j.celrep.2014.08.017.
6. Garcia-Rodriguez C., et al. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Eng. Des. Sel. 2011, 24:321-331.
7. Zuniga J.E., et al. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. PLoS ONE 2010, 30:e11378.
8. Fischer A., et al. Bimodal modulation of the botulinum neurotoxin protein-conducting channel. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1330-1335.
9. Hanschmann E.M., et al. Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling. Antioxid. Redox Signal. 2013, 19:1539-1605.
10. Lu J., Holmgren A. The thioredoxin antioxidant system. Free Radic. Biol. Med. 2014, 66:75-87.